MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines

Cell Cycle

Volumn 10, Issue 7, 2011, Pages 1121-1131

  Viticchiè, Giuditta ^a   Lena, Anna Maria ^a   Latina, Alessia ^a   Formosa, Amanda ^a   Gregersen, Lea H ^c   Lund, Anders H ^c   Bernardini, Sergio ^a   Mauriello, Alessandro ^a   Miano, Roberto ^b   Spagnoli, Luigi G ^a   Knight, Richard A ^d   Candi, Eleonora ^a   Melino, Gerry ^a,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

EMT; Invasion; Metastasis; Migration; miR 203; Proliferation; Prostate cancer

Indexed keywords

CYTOSKELETON PROTEIN; MICRO RNA 203; MICRORNA; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL KINETICS; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; MALE; PROSTATE CANCER; TARGET CELL; TUMOR SUPPRESSOR GENE;

EID: 79953649060     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.7.15180     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2007; 57:43-66; PMID: 17237035; DOI: 10.3322/canjclin.57.1.43.
2. Damber JE, Aus G. Prostate cancer. Lancet 2008; 371:1710-21; PMID: 18486743; DOI: 10.1016/ S0140-6736(08)60729-1.
3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-90; PMID: 19945376; DOI: 10.1016/j.cell.2009.11.007.
4. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010; 101:293-9; PMID: 19961486; DOI: 10.1111/j.1349-7006.2009.01419.x.
5. Garzotto M, Hung AY. Contemporary management of high-risk localized prostate cancer. Curr Urol Rep 2010; 11:159-64; PMID: 20425622; DOI: 10.1007/ s11934-010-0101-0.
6. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11:597-610; PMID: 20661255; DOI: 10.1038/nrg2843.
7. Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med 2010; 16:257-67; PMID: 20493775; DOI: 10.1016/j.molmed.2010.04.001.
8. Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene 2010; 29:937-48; PMID: 19935707; DOI: 10.1038/onc.2009.406.
9. Valastyan S, Weinberg RA. MicroRNAs: crucial multi-tasking components in the complex circuitry of tumor metastasis. Cell Cycle 2009; 8:3506-12; PMID: 19838065.
10. Bracken CP, Gregory PA, Khew-Goodall Y, Goodall GJ. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci 2009; 66:1682-99; PMID: 19153653; DOI: 10.1007/s00018-009-8750-1.
11. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial mesenchymal transition and cancer metastasis. RNA Biol 2008; 5:115-9; PMID: 19182522.
12. Gandellini P, Folini M, Zaffaroni N. Emerging role of microRNAs in prostate cancer: implications for personalized medicine. Discov Med 2010; 9:212-8; PMID: 20350487.
13. Pang Y, Young CY, Yuan H. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin 2010; 42:363-9; PMID: 20539944; DOI: 10.1093/abbs/gmq038.
14. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009; 16:206-16; PMID: 18949015; DOI: 10.1038/cgt.2008.77.
15. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res 2007; 67:6130-5; PMID: 17616669; DOI: 10.1158/0008-5472.CAN-07-0533.
16. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008; 452:225-9; PMID: 18311128; DOI: 10.1038/nature06642.
17. Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, Aberdam D, Knight RA, Melino G, et al. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ 2008; 15:1187-95; PMID: 18483491; DOI: 10.1038/cdd.2008.69.
18. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13:496-506; PMID: 18538733; DOI: 10.1016/j.ccr.2008.04.018.
19. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766-76; PMID: 19843643; DOI: 10.1093/carcin/bgp250.
20. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008; 135:255-60; PMID: 18242245; DOI: 10.1016/j. jtcvs.2007.08.055.
21. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67:2456-68; PMID: 17363563; DOI: 10.1158/0008-5472.CAN-06-2698.
22. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11:1487-95; PMID: 19935649; DOI: 10.1038/ncb1998.
23. Bae CD, Sung YS, Jeon SM, Suh Y, Yang HK, Kim YI, et al. Upregulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. J Cancer Res Clin Oncol 2003; 129:621-30; PMID: 12942315; DOI: 10.1007/s00432-003-0484-0.
24. Hong KU, Kim HJ, Bae CD, Park J. Characterization of mitosis-specific phosphorylation of tumor-associated microtubule-associated protein. Exp Mol Med 2009; 41:832-40; PMID: 19641375; DOI: 10.3858/emm.2009.41.11.089.
25. Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A, et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localization. Br J Cancer 2007; 96:296-305; PMID: 17211471; DOI: 10.1038/sj.bjc.6603545.
26. Traenka C, Remke M, Korshunov A, Bender S, Hielscher T, Northcott PA, et al. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma. Cancer Res 2010; 70:8003-14; PMID: 20924110; DOI: 10.1158/0008-5472.CAN-10-0592.
27. Fernando HS, Sanders AJ, Kynaston HG, Jiang WG. WAVE1 is associated with invasiveness and growth of prostate cancer cells. J Urol 2008; 180:1515-21; PMID: 18710763; DOI: 10.1016/j.juro.2008.06.004.
28. Roignot J, Taïeb D, Suliman M, Dusetti NJ, Iovanna JL, Soubeyran P. CIP4 is a new ArgBP2 interacting protein that modulates the ArgBP2 mediated control of WAVE1 phosphorylation and cancer cell migration. Cancer Lett 2010; 288:116-23; PMID: 19631450; DOI: 10.1016/j.canlet.2009.06.030.
29. Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, et al. Survivin is a potential mediator of prostate cancer metastasis. Int J Radiat Oncol Biol Phys 2010; 78:1095-103. PMID: 20231071; DOI: 10.1016/j.ijrobp.2009. 09.007.
30. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell 2010; 17:53-64; PMID: 20129247; DOI: 10.1016/j.ccr.2009.11.021.
31. Akech J, Wixted JJ, Bedard K, van der Deen M, Hussain S, Guise TA, et al. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 2010; 29:811-21. PMID: 19915614; DOI: 10.1038/onc.2009.389.
32. Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, et al. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer 2010; 9:258; PMID: 20863401; DOI: 10.1186/1476-4598-9- 258.
33. Brubaker KD, Vessella RL, Brown LG, Corey E. Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function. Prostate 2003; 56:13-22; PMID: 12746842; DOI: 10.1002/pros.10233.
34. Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, et al. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 2008; 68:4352-9; PMID: 18519696; DOI: 10.1158/0008-5472.CAN-07-5237.
35. Müller T, Stein U, Poletti A, Garzia L, Rothley M, Plaumann D, et al. ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo and correlates with poor survival in colorectal cancer patients. Oncogene 2010; 29:2393-403; PMID: 20154719; DOI: 10.1038/onc.2010.6.
36. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009; 69:709-17; PMID: 19147588; DOI: 10.1158/0008-5472.CAN-08-3415.
37. Wang ZX, Teh CH, Chan CM, Chu C, Rossbach M, Kunarso G, et al. The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes. Stem Cells 2008; 26:2791-9; PMID: 18757296; DOI: 10.1634/ stemcells.2008-0443.
38. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, et al. Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res; In press; PMID: 21159887; DOI: 10.1158/1078-0432.CCR-10-2619.
39. Maouche-Chrétien L, Deleu N, Badoual C, Fraissignes P, Berger R, Gaulard P, et al. Identification of a novel cDNA, encoding a cytoskeletal associated protein, differentially expressed in diffuse large B cell lymphomas. Oncogene 1998; 17:1245-51; PMID: 9771967.
40. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 2001; 98:629-34; PMID: 11149944; DOI: 10.1073/pnas.021386498.
41. Jeon SM, Choi B, Hong KU, Kim E, Seong YS, Bae CD, et al. A cytoskeleton-associated protein, TMAP/ CKAP2, is involved in the proliferation of human foreskin fibroblasts. Biochem Biophys Res Commun 2006; 348:222-8; PMID: 16876122; DOI: 10.1016/j. bbrc.2006.07.046.
42. Huang WC, Xie Z, Konaka H, Sodek J, Zhau HE, Chung LW. Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase. A signaling pathway. Cancer Res 2005; 65:2303-31; PMID: 15781644; DOI: 10.1158/0008-5472.CAN-04-3448.
43. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010; 5:8836; PMID: 20098684; DOI: 10.1371/journal.pone.0008836.